Ye Yang

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Multiple Myeloma

Tyrosine Kinase

Cell Proliferation

Acute Lymphoblastic Leukemia

Top Venues

Journal of experimental & clinical cancer research : CR

Future medicinal chemistry

OncoTargets and therapy

Journal of hematology & oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuqian Yuan, Xiaozhu Tang, Hongyan Li, Xufeng Lang, Yihua Song, Ye Yang, Zuojian Zhou
BiLSTM- and CNN-Based m6A Modification Prediction Model for circRNAs. Molecules (Basel, Switzerland) 29 (11) (2024)
Xiaozhu Tang, Mengjie Guo, Yuanjiao Zhang, Junxian Lv, Chunyan Gu, Ye Yang
Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Xiaozhu Tang, Mengjie Guo, Yuanjiao Zhang, Junxian Lv, Chunyan Gu, Ye Yang
Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Yuqian Yuan, Xiaozhu Tang, Hongyan Li, Xufeng Lang, Yihua Song, Ye Yang, Zuojian Zhou
BiLSTM- and CNN-Based m6A Modification Prediction Model for circRNAs. Molecules (Basel, Switzerland) 29 (11) (2024)
Xiaozhu Tang, Mengjie Guo, Yuanjiao Zhang, Junxian Lv, Chunyan Gu, Ye Yang
Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Yiwen Zhang, Lu Lu, Feifeng Song, Xiaozhou Zou, Yujia Liu, Xiaowei Zheng, Jinjun Qian, Chunyan Gu, Ping Huang, Ye Yang
Research progress on non-protein-targeted drugs for cancer therapy. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Qing-Xin Wang, Yu-Hao Cao, Li-Jin Yang, Yi-Yuan Ma, Nan Li, Shi-Han Wu, Lu Chen, Jia-Zhen Wu, Zhen-Jiang Tong, Xiao-Long Wang, Xin Xue, Ning Ding, Xue-Jiao Leng, Liang Chang, Wei-Chen Dai, Yan-Cheng Yu, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II. Future medicinal chemistry 15 (1) (2023)
Yiwen Zhang, Lu Lu, Feifeng Song, Xiaozhou Zou, Yujia Liu, Xiaowei Zheng, Jinjun Qian, Chunyan Gu, Ping Huang, Ye Yang
Research progress on non-protein-targeted drugs for cancer therapy. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Yiwen Zhang, Lu Lu, Feifeng Song, Xiaozhou Zou, Yujia Liu, Xiaowei Zheng, Jinjun Qian, Chunyan Gu, Ping Huang, Ye Yang
Research progress on non-protein-targeted drugs for cancer therapy. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Chao Tang, Mengying Ke, Xichao Yu, Shanliang Sun, Xian Luo, Xin Liu, Yanyan Zhou, Ze Wang, Xing Cui, Chunyan Gu, Ye Yang
GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Qing-Xin Wang, Yu-Hao Cao, Li-Jin Yang, Yi-Yuan Ma, Nan Li, Shi-Han Wu, Lu Chen, Jia-Zhen Wu, Zhen-Jiang Tong, Xiao-Long Wang, Xin Xue, Ning Ding, Xue-Jiao Leng, Liang Chang, Wei-Chen Dai, Yan-Cheng Yu, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II. Future medicinal chemistry (2023)
Qing-Xin Wang, Yu-Hao Cao, Li-Jin Yang, Yi-Yuan Ma, Nan Li, Shi-Han Wu, Lu Chen, Jia-Zhen Wu, Zhen-Jiang Tong, Xiao-Long Wang, Xin Xue, Ning Ding, Xue-Jiao Leng, Liang Chang, Wei-Chen Dai, Yan-Cheng Yu, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II. Future medicinal chemistry 15 (1) (2023)
Qing-Xin Wang, Yu-Hao Cao, Li-Jin Yang, Yi-Yuan Ma, Nan Li, Shi-Han Wu, Lu Chen, Jia-Zhen Wu, Zhen-Jiang Tong, Xiao-Long Wang, Xin Xue, Ning Ding, Xue-Jiao Leng, Liang Chang, Wei-Chen Dai, Yan-Cheng Yu, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II. Future medicinal chemistry 15 (1) (2023)
Qing-Xin Wang, Yu-Hao Cao, Li-Jin Yang, Yi-Yuan Ma, Nan Li, Shi-Han Wu, Lu Chen, Jia-Zhen Wu, Zhen-Jiang Tong, Xiao-Long Wang, Xin Xue, Ning Ding, Xue-Jiao Leng, Liang Chang, Wei-Chen Dai, Yan-Cheng Yu, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II. Future medicinal chemistry 15 (1) (2023)
Zhen Hua, Rongfang Wei, Mengjie Guo, Zigen Lin, Xichao Yu, Xinying Li, Chunyan Gu, Ye Yang
YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis. Oncogene 41 (10) (2022)
Yuanjiao Zhang, Xichao Yu, Rongze Sun, Jie Min, Xiaozhu Tang, Zigen Lin, Siyuan Xie, Xinying Li, Shengfeng Lu, Zhidan Tian, Chunyan Gu, Lesheng Teng, Ye Yang
Splicing factor arginine/serine-rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome-based cellular communication. Clinical and translational medicine 12 (2) (2022)
Rongfang Wei, Yan Zhu, Yuanjiao Zhang, Wene Zhao, Xichao Yu, Ling Wang, Chunyan Gu, Xiaosong Gu, Ye Yang
AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation. Cancer communications (London, England) 42 (11) (2022)
Fengjie Jiang, Xiaozhu Tang, Chao Tang, Zhen Hua, Mengying Ke, Chen Wang, Jiamin Zhao, Shengyao Gao, Artur Jurczyszyn, Siegfried Janz, Meral Beksac, Fenghuang Zhan, Chunyan Gu, Ye Yang
HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA. Journal of hematology & oncology 14 (1) (2021)
Mengying Ke, Liqing Kang, Ling Wang, Shu Yang, Yajun Wang, Haiyan Liu, Chunyan Gu, Hongming Huang, Ye Yang
CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients. Journal of hematology & oncology 14 (1) (2021)
Chunyan Gu, Wang Wang, Xiaozhu Tang, Tingting Xu, Yanxin Zhang, Mengjie Guo, Rongfang Wei, Yajun Wang, Artur Jurczyszyn, Siegfried Janz, Meral Beksac, Fenghuang Zhan, Anja Seckinger, Dirk Hose, Jingxuan Pan, Ye Yang
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma. Molecular cancer 20 (1) (2021)
Jianhao Hou, Jinjun Qian, Zhenlin Li, Aixiu Gong, Sixia Zhong, Li Qiao, Shihui Qian, Yanxin Zhang, Renjie Dou, Rui Li, Ye Yang, Chunyan Gu
Bioactive Compounds from Abelmoschus manihot L. Alleviate the Progression of Multiple Myeloma in Mouse Model and Improve Bone Marrow Microenvironment. OncoTargets and therapy 13 (2020)
Lili Tang, Chang Chen, Baomei Xia, Wei Wu, Ruide Wei, Guoxue Zhu, Juanjuan Tang, Xin Zhou, Yan Liang, Zhen-Nian Zhang, Yan Lu, Ye Yang, Yang Zhao
Effect of Wenshen-Yanggan Decoction on Movement Disorder and Substantia Nigra Dopaminergic Neurons in Mice with Chronic Parkinson's Disease. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
Haiyan Liu, Ye Yang, Jie Jiang, Xinfeng Wang, Chenlu Zhang, Yijing Jiang, Lemin Hong, Hongming Huang
Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy. OncoTargets and therapy 12 (2019)
Yan Liang, Chang Chen, Baomei Xia, Wei Wu, Juanjuan Tang, Qing Chen, Lili Tang, Hui Yang, Zhennian Zhang, Yan Lu, Ye Yang, Yang Zhao
Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease. BioMed research international 2019 (2019)
Dongdong Sun, Weixing Shen, Feng Zhang, Huisen Fan, Jiani Tan, Liu Li, Changliang Xu, Haibin Zhang, Ye Yang, Hai-Bo Cheng
α-Hederin Arrests Cell Cycle at G2/M Checkpoint and Promotes Mitochondrial Apoptosis by Blocking Nuclear Factor-κB Signaling in Colon Cancer Cells. BioMed research international 2018 (2018)